Literature DB >> 22102093

The field of schizophrenia: strengths, weaknesses, opportunities, and threats.

John M Kane, Barbara Cornblatt, Christoph U Correll, Terry Goldberg, Todd Lencz, Anil K Malhotra, Delbert Robinson, Philip Szeszko.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22102093      PMCID： PMC3245590          DOI： 10.1093/schbul/sbr131

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  28 in total

1.  Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.

Authors:  Neeltje E M van Haren; Hilleke E Hulshoff Pol; Hugo G Schnack; Wiepke Cahn; René C W Mandl; D Louis Collins; Alan C Evans; René S Kahn
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

2.  Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.

Authors:  Jari Tiihonen; Kristian Wahlbeck; Jouko Lönnqvist; Timo Klaukka; John P A Ioannidis; Jan Volavka; Jari Haukka
Journal:  BMJ       Date:  2006-07-06

Review 3.  Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses.

Authors:  Stefan Leucht; Sandra Hierl; Werner Kissling; Markus Dold; John M Davis
Journal:  Br J Psychiatry       Date:  2012-02       Impact factor: 9.319

4.  Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Authors:  D Robinson; M G Woerner; J M Alvir; R Bilder; R Goldman; S Geisler; A Koreen; B Sheitman; M Chakos; D Mayerhoff; J A Lieberman
Journal:  Arch Gen Psychiatry       Date:  1999-03

5.  Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients.

Authors:  W S Fenton; C R Blyler; R J Wyatt; T H McGlashan
Journal:  Br J Psychiatry       Date:  1997-09       Impact factor: 9.319

6.  Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.

Authors:  A Chatterjee; M Chakos; A Koreen; S Geisler; B Sheitman; M Woerner; J M Kane; J Alvir; J A Lieberman
Journal:  Am J Psychiatry       Date:  1995-12       Impact factor: 18.112

7.  Cognitive development in schizophrenia: follow-back from the first episode.

Authors:  Robert M Bilder; Gail Reiter; Jay Bates; Todd Lencz; Philip Szeszko; Robert S Goldman; Delbert Robinson; Jeffrey A Lieberman; John M Kane
Journal:  J Clin Exp Neuropsychol       Date:  2006-02       Impact factor: 2.475

8.  Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

Authors:  Christos Pantelis; Dennis Velakoulis; Patrick D McGorry; Stephen J Wood; John Suckling; Lisa J Phillips; Alison R Yung; Edward T Bullmore; Warrick Brewer; Bridget Soulsby; Patricia Desmond; Philip K McGuire
Journal:  Lancet       Date:  2003-01-25       Impact factor: 79.321

Review 9.  Infants at risk for psychopathology: offspring of schizophrenic parents.

Authors:  E Walker; E Emory
Journal:  Child Dev       Date:  1983-10

10.  Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis.

Authors:  Stefan J Borgwardt; Philip K McGuire; Jacqueline Aston; Gregor Berger; Paola Dazzan; Ute Gschwandtner; Marlon Pflüger; Marcus D'Souza; Ernst-Wilhelm Radue; Anita Riecher-Rössler
Journal:  Br J Psychiatry Suppl       Date:  2007-12
View more
  2 in total

1.  Epidemiological and clinical characterization following a first psychotic episode in major depressive disorder: comparisons with schizophrenia and bipolar I disorder in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).

Authors:  Olabisi Owoeye; Tara Kingston; Paul J Scully; Patrizia Baldwin; David Browne; Anthony Kinsella; Vincent Russell; Eadbhard O'Callaghan; John L Waddington
Journal:  Schizophr Bull       Date:  2013-05-28       Impact factor: 9.306

2.  DRD2 C957T polymorphism is associated with improved 6-month verbal learning following traumatic brain injury.

Authors:  John K Yue; Ethan A Winkler; Jonathan W Rick; John F Burke; Thomas W McAllister; Sam S Oh; Esteban G Burchard; Donglei Hu; Jonathan Rosand; Nancy R Temkin; Frederick K Korley; Marco D Sorani; Adam R Ferguson; Hester F Lingsma; Sourabh Sharma; Caitlin K Robinson; Esther L Yuh; Phiroz E Tarapore; Kevin K W Wang; Ava M Puccio; Pratik Mukherjee; Ramon Diaz-Arrastia; Wayne A Gordon; Alex B Valadka; David O Okonkwo; Geoffrey T Manley
Journal:  Neurogenetics       Date:  2016-11-08       Impact factor: 2.660
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.